Press Release
YILING PHARMACEUTICAL CO.LTD
Three Decades of Advancing China Traditional Medication
JAKARTA, 1 September 2022 – Traditional Chinese medicine is truly popular worldwide. Not only for the domestic market, various Medicines produced in this country are consumed all around the globe. Despite medical modernization and consistently developing marketing strategies, traditional Chinese medicine has endured.
This is demonstrated at Shijiazhuang Yiling Pharmaceutical, a high-technology pharmaceutical promoting advanced traditional Chinese medicine. Yiling Pharmaceutical was founded in 1992 by Professor Wu Yiling, a prominent member of the China Academy of Engineering. Under Wu’s leadership, this Chinese prominent pharmaceutical company established and executed five-year plans. This philosophy has taken the company owned by the 73 year old professor to success for the last 30 years. The company has grown to become China’s 500 Most Valuable Brands, Top 20 Registered Pharmaceutical Companies in China, and the Top 10 Chinese Drug Companies in China.
“Our company culture is inherit innovations that can benefit mankind’s welfare and aim at developing science and technology for a healthier future”, says Executive Vice-President of Shijiazhuang Yiling Pharmaceutical Co.Ltd, Zhang Yunling in her written statement. Zhang adds, that developments focus on health industry based on healthy technology innovation systems, market formulation, technology based development strategies and carrying out a number of scientific research and development projects, as well as establishing national marketing networks. “We also focus on building enterprise competitiveness and produce multiple scientific researches through theoretical innovation on medical treatment and traditional drugs,” she further claimed.
Zhang mentions that during the journey, Shijiazhuang Yiling Pharmaceutical has made leapfrog advancements, both for product and business. This pharmaceutical enterprise is certified, at national and international level, and meets medical standards applied in the USA, Europe Union, Canada, New Zealand and several other countries.
Traditional Chinese medicine has thrived for more than 3,000 years and is one of the priceless national cultural heritage. Shijiazhuang Yiling Pharmaceutical leads traditional medication development both academically and using Chinese Medicine Collateral Theory, which integrates innovation, clinical medication, and scientific research and development in Chinese medicine. “Its innovative medical benefits are not only recognized Worldwide, but also have scientific certification basis. The medical industry has gradually acknowledged the existence of traditional medicine in international medical communities,” claims Zhang.
As a prominent traditional Chinese pharmaceutical enterprise, Shijiazhuang Yiling Pharmaceutical Co.Ltd also plays a major role in health sector in community welfare. During the Covid-19 pandemic, the company provided positive assistance by donating products of Lianhua Qingwen capsules valued at 15 million Yuan to the China Red Cross and Wuhan city. In January 2021, this pharmaceutical company invested 50 million Yuan in China Red Cross to fund projects related to Covid-19 aimed to provide medical support, epidemic prevention, and normalization post pandemic efforts. Yiling Pharmaceutical also donated capsules valued at more than 15 million Yuan to Thailand, Cambodia, Iraq, Italy, Nepal, Ecuador, Brazil, and other countries as well as international organizations to support local epidemic mitigation. At this time, according to Zhang Yunling, Lianhua Qingwen product and other traditional Chinese medicine are widely recognized.
Download media images here: https://drive.google.com/drive/folders/1XAvEUPs6Y2P9qebu2G3JIx43mm8cd8rf?usp=sharing
Editor’s Note
About Yiling Pharmaceutical
Founded by Professor Wu Yiling, a prominent member of China Academy of Engineering in 1992, Yiling Pharmaceutical is a national innovative enterprise in China. It has made great contributions to pharmaceutical industry by integrating innovative Chinese Medicine Collateral Theory and modern high technology. Yiling has developed more than 10 patent Chinese herbal drugs, 10 clinically approved formulations, 20 formulations in clinical trials, and more than 100 in-hospital preparations, covering major disease fields of cardio-cerebrovascular, cold and respiratory, tumor, diabetes, etc. From a small clinic in 1992 to a large company, Yiling Pharmaceutical has successfully integrated its businesses of hospital, medicine and comprehensive health, and shifted their development concept from “medicine” to “big health”. Yiling Pharmaceutical has won many honorary titles such as National Key Hi-tech Enterprise, Top 20 Listed Pharmaceutical Company, etc. Their signature product, Lianhua Qingwen Capsules, is widely recognized due to its proven efficacy in combating COVID-19 and has been granted market access in more than 20 countries and regions.
Yiling Pharmaceutical
No.238 Tianshan Street, East Developing Sone
Shijiazhuang, Hebei, China
Phone: +86-311-85901712
Website: https://en.yiling.com/
Media contact:
Ms. Stella SHI
Brand Communication Department
Email: shishaokun@yiling.cn